JP6543431B2 - 眼内薬物送達デバイスおよび付随する方法 - Google Patents

眼内薬物送達デバイスおよび付随する方法 Download PDF

Info

Publication number
JP6543431B2
JP6543431B2 JP2013213155A JP2013213155A JP6543431B2 JP 6543431 B2 JP6543431 B2 JP 6543431B2 JP 2013213155 A JP2013213155 A JP 2013213155A JP 2013213155 A JP2013213155 A JP 2013213155A JP 6543431 B2 JP6543431 B2 JP 6543431B2
Authority
JP
Japan
Prior art keywords
active agent
matrix
delivery device
eye
biodegradable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013213155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015074641A5 (https=
JP2015074641A (ja
Inventor
ケー． アンバティ、バラムラリ
ケー． アンバティ、バラムラリ
ケー． ゲール、ブルース
ケー． ゲール、ブルース
ラオ チェンナマネニ、スリニヴァス
ラオ チェンナマネニ、スリニヴァス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Utah, University of, Research Foundation of
University of Utah Research Foundation Inc
Original Assignee
Utah, University of, Research Foundation of
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Utah, University of, Research Foundation of, University of Utah Research Foundation Inc filed Critical Utah, University of, Research Foundation of
Priority to JP2013213155A priority Critical patent/JP6543431B2/ja
Publication of JP2015074641A publication Critical patent/JP2015074641A/ja
Publication of JP2015074641A5 publication Critical patent/JP2015074641A5/ja
Application granted granted Critical
Publication of JP6543431B2 publication Critical patent/JP6543431B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013213155A 2013-10-10 2013-10-10 眼内薬物送達デバイスおよび付随する方法 Active JP6543431B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013213155A JP6543431B2 (ja) 2013-10-10 2013-10-10 眼内薬物送達デバイスおよび付随する方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013213155A JP6543431B2 (ja) 2013-10-10 2013-10-10 眼内薬物送達デバイスおよび付随する方法

Publications (3)

Publication Number Publication Date
JP2015074641A JP2015074641A (ja) 2015-04-20
JP2015074641A5 JP2015074641A5 (https=) 2016-11-17
JP6543431B2 true JP6543431B2 (ja) 2019-07-10

Family

ID=52999772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013213155A Active JP6543431B2 (ja) 2013-10-10 2013-10-10 眼内薬物送達デバイスおよび付随する方法

Country Status (1)

Country Link
JP (1) JP6543431B2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018125930A1 (en) * 2016-12-27 2018-07-05 University Of Utah Research Foundation Intraocular drug delivery device and associated methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720859B2 (ja) * 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
JP2002531217A (ja) * 1998-12-04 2002-09-24 チャンドラシェカー ピー． パサック， 生体適合性架橋ポリマー
AU2002236495B2 (en) * 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
TWI369218B (en) * 2004-12-14 2012-08-01 Novartis Ag In situ forming implant for animals
ATE454908T1 (de) * 2005-09-21 2010-01-15 Surmodics Inc In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
BRPI0604577B8 (pt) * 2006-08-31 2021-05-25 Univ Minas Gerais formulação farmacêutica para administração intraocular de fármacos e processo de obtenção

Also Published As

Publication number Publication date
JP2015074641A (ja) 2015-04-20

Similar Documents

Publication Publication Date Title
US9877973B2 (en) Intraocular drug delivery device and associated methods
AU2019250153B2 (en) Methods and biocompatible compositions to achieve sustained drug release in the eye
US10064819B2 (en) Intraocular drug delivery device and associated methods
JP6700348B2 (ja) 持続型薬物送達インプラント
JP6132964B2 (ja) 萎縮性加齢性黄斑変性の処置方法
Chennamaneni et al. Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation
JP7848190B2 (ja) 生体侵食性眼薬送達挿入物及び治療方法
RU2729731C2 (ru) Составы на основе сунитиниба и способы их применения для лечения глазных заболеваний
CA2830555A1 (en) Intraocular drug delivery device and associated methods
Eperon et al. A biodegradable drug delivery system for the treatment of postoperative inflammation
US10588855B2 (en) Intraocular drug delivery device and associated methods
JP2020514404A (ja) 眼内薬物送達デバイス及び関連方法
JP6543431B2 (ja) 眼内薬物送達デバイスおよび付随する方法
AU2019204106A1 (en) Intraocular drug delivery device and associated methods
Capítulo Nanoparticles as ocular drug delivery systems
HK40118703A (zh) 治疗湿性年龄相关性黄斑变性的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160930

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170711

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171006

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180626

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180921

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190426

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190521

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190615

R150 Certificate of patent or registration of utility model

Ref document number: 6543431

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250